The compromised inflammatory response to bacterial components after pediatric cardiac surgery is associated with cardiopulmonary bypass-suppressed Toll-like receptor signal transduction pathways

J Crit Care. 2014 Apr;29(2):312.e7-13. doi: 10.1016/j.jcrc.2013.10.008. Epub 2013 Oct 28.

Abstract

Purpose: Cardiopulmonary bypass (CPB) during pediatric cardiac surgery often elicits a systemic inflammatory response followed by a compromised immune response, which has been attributed to the morbidity of postoperative infection; however, the underlying mechanism(s) has not yet been fully elucidated. We hypothesized that CPB inhibits the activation of Toll-like receptor (TLR) signal transduction pathways, thereby causing an immunosuppressive state after pediatric cardiac surgery.

Methods: We examined 20 children with congenital heart disease undergoing pediatric cardiac surgery.

Results: Cardiopulmonary bypass differentially affected lipopolysaccharide (LPS)- or bacterial lipoprotein (BLP)-stimulated ex vivo production of proinflammatory and anti-inflammatory cytokines, with significantly diminished tumor necrosis factor α, interleukin (IL) 1β, IL-6, and IL-8, but substantially enhanced IL-10 production. Consistent with the reduced inflammatory response, CPB strongly inhibited LPS- or BLP-activated TLR signal transduction pathways in monocytes with down-regulated expression of CD14, TLR4, and TLR2 and with suppressed phosphorylation of nuclear factor κB p65, p38, and extracellular signal-regulated kinase 1/2.

Conclusions: These results indicate that CPB during pediatric cardiac surgery causes substantially reduced production of inflammatory cytokines in response to bacterial component LPS or BLP stimulation, which is associated with CPB-induced suppression of TLR-mediated signal transduction pathways. This reduced inflammatory response after CPB in children with congenital heart disease may predispose them to an increased risk of postoperative infection.

Keywords: Cardiopulmonary bypass; Congenital heart disease; Inflammatory responses; Intracellular signal pathways; TLR signaling.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiopulmonary Bypass / adverse effects*
  • Cytokines / biosynthesis*
  • Female
  • Heart
  • Heart Defects, Congenital / immunology
  • Heart Defects, Congenital / metabolism
  • Heart Defects, Congenital / surgery*
  • Humans
  • Infant
  • Interleukin-10 / biosynthesis
  • Interleukin-1beta / biosynthesis
  • Interleukin-6 / biosynthesis
  • Interleukin-8 / biosynthesis
  • Lipopolysaccharide Receptors / biosynthesis
  • Lipopolysaccharides / immunology
  • Lipoproteins / immunology
  • Male
  • Monocytes
  • Signal Transduction
  • Systemic Inflammatory Response Syndrome / complications
  • Systemic Inflammatory Response Syndrome / immunology*
  • Toll-Like Receptor 2 / biosynthesis
  • Toll-Like Receptor 4 / biosynthesis
  • Toll-Like Receptors / metabolism*
  • Tumor Necrosis Factor-alpha / biosynthesis

Substances

  • Cytokines
  • Interleukin-1beta
  • Interleukin-6
  • Interleukin-8
  • Lipopolysaccharide Receptors
  • Lipopolysaccharides
  • Lipoproteins
  • Toll-Like Receptor 2
  • Toll-Like Receptor 4
  • Toll-Like Receptors
  • Tumor Necrosis Factor-alpha
  • Interleukin-10